Skip to content

Drug interactions

Losartan + Nateglinide

Severity: Minor

Losartan and Nateglinide: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Nateglinide is a CYP2C9 substrate and weak inhibitor in vitro, and could theoretically reduce activation of losartan to E-3174. Clinical relevance has not been shown and no meaningful effect is expected in practice.

What this interaction means in plain words

Losartan and Nateglinide have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Losartan belongs to Cardiovascular; Nateglinide belongs to Endocrine.

Evidence level: Low

Why it happens

Possible competitive inhibition of CYP2C9 conversion of losartan to its active metabolite.

What to do

No dose change is needed; monitor blood pressure and glucose as usual.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Losartan and Nateglinide, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Losartan with Nateglinide?

MediHelp rates the interaction as minor. Losartan and Nateglinide have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Nateglinide is a CYP2C9 substrate and weak inhibitor in vitro, and could theoretically reduce activation of losartan to E-3174. Clinical relevance has not been shown and no meaningful effect is expected in practice.

How serious is the interaction between Losartan and Nateglinide?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No dose change is needed; monitor blood pressure and glucose as usual.

What other medicines interact with Losartan?

MediHelp also lists interactions of Losartan with, for example, Aliskiren, Sparsentan, Amifostine. The full list is on the Losartan page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in